| Dr Melvin Wagner, MD | |
|
338 Alexander Spring Rd, Carlisle, PA 17015-9129 | |
| (717) 249-6337 | |
| Not Available |
| Full Name | Dr Melvin Wagner |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 27 Years |
| Location | 338 Alexander Spring Rd, Carlisle, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013943950 | NPI | - | NPPES |
| 408597300 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | D62561 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stoken Wagner Ophthalmic Associates Llc | 6608177472 | 5 |
News Archive
Fibromyalgia, a chronic, widespread pain in muscles and soft tissues accompanied by fatigue, is a fairly common condition that does not manifest any structural damage in an organ.
UT Southwestern Medical Center psychiatry researchers have taken what they learned from their groundbreaking research on treating depression and are applying it to real-world clinical settings.
CareFirst BlueCross BlueShield, the largest private insurer in the Washington [DC] region, plans to announce Tuesday that it will give $8.5 million to a dozen safety-net clinics to help them use a coordinated primary-care approach to treat their most vulnerable patients, executives said. ... One of the recipients is the Arlington Free Clinic, which provides free health care to about 1,600 low-income, uninsured residents.
ChemoCentryx, Inc., today announced that it reported positive data with Traficet-EN™ (CCX282-B) in the Maintenance period of PROTECT-1 (Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial-1). Traficet-EN maintained a clinical remission rate (Crohn's Disease Activity Index (CDAI) less than 150) of approximately 50% in Crohn's patients over the course of 36 weeks, whereas in the placebo group remission decreased progressively from 50% to 31%.
› Verified 3 days ago
| Entity Name | Stoken Wagner Ophthalmic Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306213319 PECOS PAC ID: 6608177472 Enrollment ID: O20151221001326 |
News Archive
Fibromyalgia, a chronic, widespread pain in muscles and soft tissues accompanied by fatigue, is a fairly common condition that does not manifest any structural damage in an organ.
UT Southwestern Medical Center psychiatry researchers have taken what they learned from their groundbreaking research on treating depression and are applying it to real-world clinical settings.
CareFirst BlueCross BlueShield, the largest private insurer in the Washington [DC] region, plans to announce Tuesday that it will give $8.5 million to a dozen safety-net clinics to help them use a coordinated primary-care approach to treat their most vulnerable patients, executives said. ... One of the recipients is the Arlington Free Clinic, which provides free health care to about 1,600 low-income, uninsured residents.
ChemoCentryx, Inc., today announced that it reported positive data with Traficet-EN™ (CCX282-B) in the Maintenance period of PROTECT-1 (Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial-1). Traficet-EN maintained a clinical remission rate (Crohn's Disease Activity Index (CDAI) less than 150) of approximately 50% in Crohn's patients over the course of 36 weeks, whereas in the placebo group remission decreased progressively from 50% to 31%.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melvin Wagner, MD 338 Alexander Spring Rd, Carlisle, PA 17015-9129 Ph: (717) 249-6337 | Dr Melvin Wagner, MD 338 Alexander Spring Rd, Carlisle, PA 17015-9129 Ph: (717) 249-6337 |
News Archive
Fibromyalgia, a chronic, widespread pain in muscles and soft tissues accompanied by fatigue, is a fairly common condition that does not manifest any structural damage in an organ.
UT Southwestern Medical Center psychiatry researchers have taken what they learned from their groundbreaking research on treating depression and are applying it to real-world clinical settings.
CareFirst BlueCross BlueShield, the largest private insurer in the Washington [DC] region, plans to announce Tuesday that it will give $8.5 million to a dozen safety-net clinics to help them use a coordinated primary-care approach to treat their most vulnerable patients, executives said. ... One of the recipients is the Arlington Free Clinic, which provides free health care to about 1,600 low-income, uninsured residents.
ChemoCentryx, Inc., today announced that it reported positive data with Traficet-EN™ (CCX282-B) in the Maintenance period of PROTECT-1 (Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial-1). Traficet-EN maintained a clinical remission rate (Crohn's Disease Activity Index (CDAI) less than 150) of approximately 50% in Crohn's patients over the course of 36 weeks, whereas in the placebo group remission decreased progressively from 50% to 31%.
› Verified 3 days ago
Drew Joseph Stoken, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 338 Alexander Spring Rd, Carlisle, PA 17015 Phone: 717-249-6337 Fax: 717-249-2415 | |
David Larry Hartzell, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 37 Brookwood Ave, Carlisle, PA 17013 Phone: 717-243-8606 Fax: 717-243-7221 | |
David Leigh Hartzell, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 37 Brookwood Ave, Carlisle, PA 17013 Phone: 717-243-8606 Fax: 717-243-7221 | |
Dr. Julian A Procope, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 220 Wilson St, Suite 207, Carlisle, PA 17013 Phone: 717-243-2300 Fax: 717-258-0928 |